Table 3.
Serious adverse events.
| Serious adverse events | NIHP (n = 6) | SCS (n = 25) | RR |
|---|---|---|---|
| Acute cardiac failure | 0 | 3 (12%) | – |
| Acute bleeding (BARC type IV)a | 0 | 6 (24%) | – |
| Respiratory failure | 2 (33%) | 8 (32%) | 1.04 (0.29–3.7) |
| Acute kidney failure (KDIGO)a | 5 (83%) | 17 (68%) | 1.23 (0.78–1.9) |
| Acute liver failure | 0 | 0 | – |
| Permanent stroke | 0 | 0 | – |
| Permanent pacemaker | 0 | 4 (16%) | – |
Data are n (%).
NIHP nonischemic heart preservation, RR relative risk, SCS static cold storage.
aFor definition see online methods.